Abbreviations/Words |
Meaning |
Aa |
Amino Acid |
Ab |
Antibody |
Adhesion Molecules |
Membrane-expressing molecules that mediate two cells to interact, e.g., a stem cell and a cells within a microenvironment such as stroma. An adhesion molecular can also mediate an interaction between thel cell and the extracellular matrix proteins. |
Adipose cells |
Fat cells in the bone marrow |
Ag |
Antigen |
AGM |
Aorta-gonads-mesonephros: Site LHSC in the embryo. |
Angiogenesis |
The growth and sprouting of additional blood vessels from pre-existing blood vessels |
AML |
Adult Myeloid Leukemia |
Anoikis |
Apoptosis, induced by anchorage-dependent cells detaching from ECM |
APC |
Antigen Presenting Cell |
Asymmetric Division |
One daughter cell quiescent and the other proliferating and moving away from site of division |
Altered Nuclear Transfer (ANT) |
The adult cells is engineered to switch off a gene to prevent the developed embryos from implanting. Thus, the method does not allow for cloning of a person. The Cdx2 gene has been targeted to test proof of principle. |
Autophagy |
Self-eating cells: Delivery of cytoplasmic constituents such as whole organels to the lysosome for degradation. Occurs during starvation, aging and development. It is a recycling process. |
BFU-E |
Erythrocyte Burst Forming Unit (Early erythroid progenitors) |
Bipolar Stem Cell |
The cell can form two lineages |
Blastocyte (or blastula) |
4-5 day embryo formed prior to implantation in the uterus. Is comprised of a hollow mass of only a few undifferentiated stem cells. |
Blastomere |
Single cells taken from 8-cell embryos |
BM |
Bone Marrow |
Bp |
Base pair |
BSA |
Bovine Serum Albumin |
CD |
Cluster Designation: Used with a number to indicate a cell surface marker. |
CD33 |
Present on committed progenitors in the myeloid lineages. |
CD34 |
Present on Lymphohematopoietic stem cells and their progenitors. Express at high densities in the most primitive cells and become dim as the cells mature towards differentiation. |
CD38 |
Not detectable on Lymphohematopoietic stem cells but begin to appear as the cells commit towards a lineage. |
CD133 |
Also referred as Prominin. A marker of LHSC and perhaps NSCs |
Cell Release |
Movement of bone marrow cells out of the sinus into the peripheral circulation. |
CFU |
Colony Forming Unit |
CFU-E |
Erythrocyte Colony Forming Unit (Late stage erythrocyte progenitors) |
CFU-GM |
Granulocyte-Macrophage Colony Forming Unit |
CFU-S |
Colony Forming Unit- Spleen |
Chemoattractant |
A factor that attract a cell, e.g., a cytokine or a chemokine |
Chemotaxis |
Attraction of a cell to an area where there is a gradient increase of a particular factor |
CLP |
Common Lymphoid Progenitor |
CMP |
Common Myeloid Progenitor |
CNS |
Central Nervous System |
Cloning |
The method of desilencing genes in adult specialized cells by proteins in an egg (oocyte). The technique entails removing the nuclei material from an egg and replacing with the genetic material from the specialized cells. |
cRNA |
Complementary RNA |
CSF |
Colony stimulating factors: Generally referred to groups of cytokines and other growth factors that can stimulate Lymphohematopoietic stem cells and bone marrow progenitors. (In general, they are the hematopoietic stimulators) |
CXCR, CXC |
Chemokine receptor |
Cytokines |
A family of small labile molecules that seem functionally redundant. They are mostly naturally glycoprotein and are important in regulating the maturation of bone marrow stem cells. |
Da |
Dalton (kDa: kilodalton) |
Differentiation |
Downward steps towards the development of mature immune and blood cells |
De-differentiation |
Backward movement of differentiated cells to immature types. |
DC |
Dendritic Cells |
Definitive LHSC
Pre-definitive LHSC |
Functional migrating cells that can home to the bone marrow and repopulate the host. |
De-silence or retro-differentiation |
The method to re-express all genes in adult specialized cells. This could be in form of cloning or iPS. |
DNA |
Deoxyribonucleic acid |
dsDNA |
Double-stranded DNA |
Diapedesis |
Transendothelial migration |
EC |
Endothelial Cells |
EGC |
Embryonic Germ Cells |
Endoderm |
The extra-embryonic tissue that gives rise to the visceral
and parietal endoderm. It diverges from the inner cell mass to form the outer layer of the embryo. |
Ensoulment |
When an embryo attain a soul |
EPC |
Endothelial Progenitor Cells or Adult Angioblasts |
Epigenetic |
Alterations in gene-expression patterns, without changes in DNA sequence. This could occur by modification of proteins that surround the genomic DNA, e.g.,
- Cytosine DNA methytlation (a methyl group is transferred from S-adenosylmethionine to C-5 position of cytosine by a family of cytokine-methyltransferases. This generally occurs at CpG nucleotides and is important in the regulation of gene expression and silencing.
- Genomic Imprinting: Silencing of a parental gene.
- Histone Modifications: Acetylation, methylation and phosphorylation.
|
Epigenetic Inheritance |
Transmission of non-DNA sequence via meiosis or mitosis. |
- Euchromatin |
DNA open and available |
- Heterochromatin |
DNA not available |
Epimorphic Regeneration |
Amputation and full regeneration from a stump |
Epo |
Erythropoietin (a hormone that stimulate erythropoiesis) |
Erythropoiesis |
Development of red blood cells |
ETP |
Early T-lineage Progenitor |
ELP |
Earliest Rag+ lymphocyte progenitor |
Extravasation |
Movement of a cell in or out of the bone marrow through endothelial barrier. Chemotaxis cannot account for this type of movement. |
Extravascular Compartment |
Areas in the bone marrow microenvironment that are not blood vessels |
ECM |
Extracellular matrix: Fibronectin, collagen etc.
Excreted from stromal cells and regulate functions in bone marrow, in particular, LymphoHematopoietic Stem Cells |
Embryonic carcinoma |
A type of testicular cancer that maintains the potential to give rise to mature tissues. |
EPC |
Endothelial Progenitor Cell |
ES |
Embryonic Stem Cell |
hESC (NIH definition) |
“Cells that are derived from the inner cell mas of blastocyt stage human embryos, are capable of dividing without differentiating for a prolonged period in culture, and are known to develop into cells and tissues of the three germ layers” |
Extramedullary |
Outside the bone marrow |
FACS |
Fluorescence-activated cell sorter |
Fetal Microchimerism |
Following pregnancy, a few fetal cells persist in the mom’s body for long periods of time, even decades. |
FITC |
Fluorescein isothiocyanate (Use to tag other proteins (e.g., antibodies) for immunofluorescence) |
FL |
Fetal Liver |
FCS |
Fetal Calf Sera |
FSC |
Forward Scatter |
G-CSF |
Granulocyte colony stimulating factor: Used to mobilize bone marrow in the periphery and to differentiate granulocyte precursor to neutrophils. |
GM-CSF |
A cytokine: Granulocyte-Macrophage colony stimulating factor: Growth factors for Lymphohematopoietic stem cells. |
GMP |
Granulocyte/macrophage progenitor |
Genomic Imprinting |
The expression of a gene depending on which parental allele is expressed. |
Haploinsufficiency |
Expression of one allele is repressed. This could be caused by knockdown or mutation of one allele. This leads to reduced level of a particular protein or levels. |
Harvesting |
Collecting bone marrow cells for transplantation |
Hematopoiesis |
Formation of 8 distinct lineages from a Lymphohematopoietic Stem Cell (LHSC) |
Heterokaryon |
The fusion of two cells resulting in two nuclei. |
Hemato-lymphoid system |
Reference to the hematopoietic system to include both the lymphoid and myeloid compartments |
Hgb |
Hemoglobin |
HLA-DR |
Hluman Histocompatibility Leukocyte Antigen-DR (analogous to MHC-Class II) |
HME |
Hematopoietic/Bone Marrow Microenvironment |
Homing |
A cell when transplanted, goes to a particular site through specific, e.g., if a Lymphohematopoietic stem cells given intravenously goes directly to the bone marrow and forms its niche in the area of stromal cells. |
Homokines |
Dual role of a factor as a hormone and as a cytokine |
HUVEC |
Human Umbilical Vein Endothelial Cells |
IPs |
Induced pluripotency, the method by which genes are expressed in adult cells to generate ESC-like cells |
IFN |
Interferon |
iPS |
Inducible Pluripotent Stem Cells: A method to insert genes to desilence adult stem cells to functional ESCs |
Interleukins |
A growing family of cytokines. To date there are 22 members in the family. |
Intramedullary |
Inside the bone marrow |
Intravascular Compartment |
Blood vessels within the bone marrow microenvironment |
IVF |
In vitro fertilization |
LHSC (sometimes referred as HSC) |
LymphoHematopoietic Stem Cell |
Lin (-) |
When several antibodies are used to deplete committed progenitors. The remaining cells are lineage negative (Lin -). |
Lymphohematopoietic (LHSC): General |
Bone Marrow System that generates immune and blood cells. |
LHSC (human) |
In general: CD34+/Lin - |
LHSC (mouse) |
Sca1+/s-kit+/Lin- |
LN |
Lymph node |
Loss of Heterozygosity (LOH) |
The allele is duplicated into the homozygous causing overexpression of the gene. |
LTC-IC |
Long term culture initiating cells assay (To study primitive bone marrow progenitors) |
LT-HSC |
Long-term hematopoietic stem cell |
Lymphopoiesis |
Development of lymphoid cells: T-cell, B-cells, NK cells and Dendritic cells, DC (only if NK and DC cells are formed from the lymphoid lineages) |
Mature |
Usually referred to the differentiated cells of hematopoietic lineages. |
M-CSF |
Monocyte-Colony Stimulating Factor |
Megakaryocyte |
Cells of myeloid lineage that differentiate into platelets |
MEP |
Megakaryocyte/erythrocyte progenitor |
Mesengenic Process |
The genesis of mesordermal tissues, such as bone, cartilage, muscle, marrow stroma, tendon, fat, dermis and connective tissues. This process occurs in adults as well as in embryos. |
Mesoderm |
The middle germ layer of the developing embryo that occupies an intermediate position between the ectoderm and the endoderm, and forms the skeleton, muscles and connective tissue. |
MHC-Class I |
Major Histocompatibility Complex, Class I: Expressed on all cells. |
MHC-Class II |
Major Histocompatibility Complex, Class II: Expressed on bone marrow Lymphohematopoietic stem cells, antigen presenting cells, mesenchymal stem cells, activated T-cells |
Microenvironment |
The structures, cells, factors (e.g., ECM), nerve fibers etc that comprise the bone marrow/hematopoietic system. |
Migration |
Cells that move from one site to the other, in the absence of a known chemoattractant. |
MK |
Megakaryocyte |
MLR |
Mixed Lymphocyte Reaction |
MΦ |
Macrophage |
MNC |
Mononuclear Cells |
Mobilization |
Injecting a chemoattractant to move stem cells from the bone marrow into the periphery. |
Monopotent |
A bone marrow progenitor that has matured but is committed towards one lineage. |
Morula |
Spheroidal mass of cells from early cleavage divisions of the zygote. |
MPP |
Multipotent Progenitor |
mRNA |
Messenger RNA |
MSC |
Mesenchymal Stem Cell |
Multipotent |
A multipotent cell can self-renew but can only form cells of one germ layer, e.g. hematopoietic stem cells.
Mulitpotent is also used to determine a committed cell, which is close in maturation to a pluripotent cell (e.g., hematopoietic stem cell), but can form less lineages. Thus, a multipotent cell has less potential to survive for a long period as compared to a pluripotent stem cell. These types of cells are considered as `cell in transition’. |
Myelopoiesis |
Lineages distinct from the lymphoid lineages. |
Niche |
Stabilization of a cell in a particular microenvironment and area of the bone marrow. |
NK |
Natural Killer cells |
NSC |
Neural Stem Cell |
Nuclear Transfer |
The removal of nucleus from a donor cell and transfer to an egg in which its nuclear DNA has been removed. The resulting embryos will match the donor and not the host. |
Oct4 |
Octamer Binding Factor: Important in ES and prevents differentiation. |
Ontogeny |
Development of Lymphohematopoietic System |
Parous |
Has given birth at least once |
Parthenogenesis |
Embryonic development from oocyte in the absence of spermatozoon. Lack potential for full-term delivery; Suggested for therapies. |
PBMC |
Peripheral Blood Mononuclear Cells |
Pericyte |
This is an old terminology. Currently, these cells might be the recently defined mesenchymal stem cells. |
Polycomb |
Protein family linked to maintaining stable and heritable
repression of several genes. |
Pluripotency |
A self-renewing cell that has the capability to commit toward different cell lineages of at least two of the three germ layers: endoderm, ectoderm and mesoderm.
E.g., ESCs, which can form all cell lineages of the body, including germ cells are pluripotent cells. |
PMN |
Polymorphonuclear Cells (e.g., neutrophils) |
Precursor |
The stage of lineage just before the differentiated cell. |
Preimplantation genetic diagnosis (PGD) |
The method is used in in vitro fertilization. A blastomere is removed at the 8-cell stage for genetic testing before implantation. |
PGD/HLA testing |
Done with the intent of knowing the type of CB for use in a diseased sibling, refer as PGD/HLA testing type 1. |
PGD/HLA testing type 2 |
|
Primitive LHSC |
Cells cannot home to the bone marrow and repopulate a host. Needs to undergo maturation on stromal cells and cytokines. |
Reticular Cell |
Non-descript cells in the bone marrow that have not been characterized. Sometimes fibroblasts and mesenchymal stem cells are referred as reticular cells. |
RNA |
Ribonucleic Acid |
Sca-1 |
Stem Cell Antigen-1 |
SCID |
Severe Combined Immundeficiency |
SSEA |
Stage-specific embryonic antigen |
SH-2, -3, -4 |
Markers developed by Osiris Biotechnology to detect mesenchymal stem cells.
SH-2 has the specificity as for CD105 (endoglin) and SH-4 for stro-1 |
Sinus |
Marrow sinus: Area of the blood vessels where the arterial and venous blood mix. Mature hematopoietic cells and other bone marrow cells exist through the sinus into the peripheral circulation. |
Spln |
Spleen |
SRC |
SCID repopulating cells |
SSC |
Side Scatter |
Stochastic |
Random |
Stroma |
The supporting layer of hematopoiesis in bone marrow |
ST-HSC |
Short-term hematopoietic stem cell |
Syncytium |
The formation of multinucleated giant cells. These could be naturally occurring fusion, eg., during development to form bone, muscle and placenta. |
Synkaryon |
After cell-cell fusion, the emergence of a single nucleated cell. A heterokaryon is formed as an intermediate step. The heterokaryon will have both nucleus. A classical example is the formation of hybridoma. |
TBI |
Total Body Irradiation |
TdT |
Terminal deoxynucleotidyltransferase |
TERT |
Telomerase reverse transcriptase (hTERT = human…) |
Teratoma |
Tumors containing cells from the three primary germ layers; A benign tumor; Can develop into teratocarcinoma |
TF |
Transcription Factor |
Tg |
Transgenic |
TGF- |
Transforming Growth Factor |
Therapeutic Cloning |
The method is similar to cloning of a mammal, except that the newly formed ESCs are used to generate specialized cells for transplantation in a diseased model. The advantage is the formation of autologous cells, which will eliminate rejection. |
TNF- |
Tumor Necrosis Factor- |
Totipotent |
Unlimited potential to differentiate into cells of the three germ layers, germ cells and extra-embryonic cells such as plancent. Thus, in this definition, only blastomeres are totipotent cells since ESC, in vitro cannot produce these cells. |
TPO |
Thrombopoietin |
Trabeculae |
Soft bones in the marrow compartment |
Transdifferentiation 1 |
A stem cell of one germ layer forming cells of another germ layer, e.g., a mesodermal stem cells forming specialized ectodermal cells.
Transdifferentiation is also used in reference of cells of one lineage forming cells of another lineage, e.g., lymphoid cells forming myeloid type cells. |
Transdifferentiation 2 |
Stem cells in one organ forming differentiated cells of another organ, e.g., bone marrow stem cells forming hepatocytes. |
Traffic |
Trafficking or circulation of cells refer to the movement of cells out of the bone marrow and through the periphery. The cells might return to the bone marrow. |
Translocation |
Breaking part of a chromosome to another chromosome, e;g., bcr-abl oncogene formed by translocation, t(9:22) as seen in chronic myeloid leukemia (CML). |
Trophoectoderm |
The outer layer of the blastocyst. |
UCB |
Umbilical Cord Blood |
Vasculogenesis |
Formation of primitive vascular networks from endothelial progenitors. |
Veto Cells |
Cells that induce apoptosis in effector cells such as CD8+ T-cells, through the recognition of the disparate MHC antigens.
Mesenchymal stem cells have been reported to exert veto functions. As third party stem cells, they can suppress allogeneic responses between T-cells from different donors. |
vWF |
von Willebrand Factor (a marker of endothelial cells) |
YS |
Yolk Sac |
Zygote |
Diploid cell of fusion between male and female gametes at fertilization. |